| Publication |
Sentence |
Publish Date |
Extraction Date |
Species |
| Michelle Iris Jakobsen, Stephen Fitzgerald Austin, Ole Jakob Storebø, Jimmi Nielsen, Erik Simonse. Non-prescribing of clozapine for outpatients with schizophrenia in real-world settings: The clinicians' perspectives. Schizophrenia (Heidelberg, Germany). vol 9. issue 1. 2023-12-22. PMID:38135678. |
clozapine is the gold standard for treating treatment-resistant schizophrenia although continuously underutilized. |
2023-12-22 |
2023-12-25 |
Not clear |
| Jing Ding, Jianfeng Liu, Yan Zhang, Huan Xing, Yang Zhang, Luyao Li, Suo Zhang, Huiyuan Wang, Liu Yang, Xiaohua Cu. A retrospective study of clozapine and norclozapine concentration in patients with schizophrenia: Data from the Therapeutic Drug Monitoring Service, 2019-2022. Asian journal of psychiatry. vol 91. 2023-12-19. PMID:38113699. |
a retrospective study of clozapine and norclozapine concentration in patients with schizophrenia: data from the therapeutic drug monitoring service, 2019-2022. |
2023-12-19 |
2023-12-23 |
Not clear |
| Ellen Kingston, Malcolm Tingle, Brandi L Bellissima, Nuala Helsby, Kathryn Burn. CYP-catalysed Cycling of Clozapine and Clozapine- Xenobiotica; the fate of foreign compounds in biological systems. 2023-12-18. PMID:38108307. |
cyp-catalysed cycling of clozapine and clozapine- clozapine is an effective atypical antipsychotic indicated for treatment-resistant schizophrenia but is under-prescribed due to the risk of severe adverse drug reactions such as myocarditis. |
2023-12-18 |
2023-12-21 |
Not clear |
| Fatemeh Mohammad-Gholizad, Iman Karimzadeh, Ebrahim Moghimi-Sarani, Mahdi Arshadi, Negar Mortazav. Evaluation and Comparison of the Effectiveness of Atropine Eye Drops, Ipratropium Bromide Nasal Spray, and Amitriptyline Tablet in the Management of Clozapine-Associated Sialorrhea in Patients With Refractory Schizophrenia: A Randomized Clinical Trial. Journal of clinical psychopharmacology. vol 44. issue 1. 2023-12-15. PMID:38100776. |
clozapine, a second-generation antipsychotic medication, is mainly indicated for managing treatment-resistant schizophrenia. |
2023-12-15 |
2023-12-18 |
Not clear |
| Liang Lv, Ping Guo, Min Feng, Yu Fang, Shi-Kai Wang, Huan-Xin Che. Multiple therapies relieve long-term tardive dyskinesia in a patient with chronic schizophrenia: A case report. World journal of clinical cases. vol 11. issue 32. 2023-12-11. PMID:38073685. |
we successfully treated a chronic schizophrenia patient with comorbid long-term severe td using deutetrabenazine, clozapine, and mect. |
2023-12-11 |
2023-12-17 |
Not clear |
| Xenia A K Kersting, Nicoletta Momtahen, Klaus Lie. Clozapine Serum Concentrations Are Disrupted by SARS-CoV-2 Vaccinations. Case reports in psychiatry. vol 2023. 2023-12-07. PMID:38058314. |
this paper reports the case of a 27-year-old man with paranoid schizophrenia who was finally stabilized on clozapine medication. |
2023-12-07 |
2023-12-10 |
Not clear |
| Andrea Amerio, Luca Magnani, Gabriele Arduino, Fabio Fesce, Renato de Filippis, Alberto Parise, Alessandra Costanza, Khoa D Nguyen, Daniele Saverino, Domenico De Berardis, Andrea Aguglia, Andrea Escelsior, Gianluca Serafini, Pasquale De Fazio, Mario Amor. Immunomodulatory Effects of Clozapine: More Than Just a Side Effect in Schizophrenia. Current neuropharmacology. 2023-12-04. PMID:38031778. |
immunomodulatory effects of clozapine: more than just a side effect in schizophrenia. |
2023-12-04 |
2023-12-10 |
Not clear |
| Tomihisa Niitsu, Norio Yasui-Furukori, Ken Inada, Tetsufumi Kanazawa, Masaomi Iyo, Takefumi Ueno, Ryota Hashimot. Current practice for clozapine-induced leukopenia in Japanese psychiatric hospitals: A nationwide survey. Schizophrenia research. 2023-12-01. PMID:38038428. |
clozapine is an atypical antipsychotic used for treatment-resistant schizophrenia. |
2023-12-01 |
2023-12-10 |
Not clear |
| Nadine Halawa, Mackenzie Armstrong, Sarah Fancy, Sabina Abid. Clozapine-induced myocarditis and subsequent rechallenge: a narrative literature review and case report. Journal of the Canadian Academy of Child and Adolescent Psychiatry = Journal de l'Academie canadienne de psychiatrie de l'enfant et de l'adolescent. vol 32. issue 4. 2023-11-30. PMID:38034406. |
clozapine is an antipsychotic medication that has been proven effective for the management of treatment-resistant schizophrenia (trs). |
2023-11-30 |
2023-12-10 |
Not clear |
| Nisha Chandrakant Bhavsar, Julie Ann Dopheide, Timothy Eugene Botello, Mengxi Wan. Therapeutic Drug Level Monitoring of Antipsychotics at an Inpatient Psychiatric Hospital. Therapeutic drug monitoring. 2023-11-29. PMID:38018824. |
the american psychiatric association guidelines for the treatment of patients with schizophrenia state that the utility of antipsychotic therapeutic drug monitoring (tdm) remains unclear, except for clozapine or assessing adherence. |
2023-11-29 |
2023-12-07 |
Not clear |
| Yuki Kikuchi, Yuji Yada, Yuji Otsuka, Fumiaki Ito, Hiroaki Tanifuji, Hiroshi Komatsu, Hiroaki Tomit. Slower clozapine titration is associated with delayed onset of clozapine-induced fever among Japanese patients with schizophrenia. Schizophrenia (Heidelberg, Germany). vol 9. issue 1. 2023-11-24. PMID:37985654. |
slower clozapine titration is associated with delayed onset of clozapine-induced fever among japanese patients with schizophrenia. |
2023-11-24 |
2023-11-28 |
Not clear |
| Yuki Kikuchi, Yuji Yada, Yuji Otsuka, Fumiaki Ito, Hiroaki Tanifuji, Hiroshi Komatsu, Hiroaki Tomit. Slower clozapine titration is associated with delayed onset of clozapine-induced fever among Japanese patients with schizophrenia. Schizophrenia (Heidelberg, Germany). vol 9. issue 1. 2023-11-24. PMID:37985654. |
we retrospectively analyzed the correlation between clozapine titration rate and fever onset date in 254 japanese patients, including 55 with treatment-resistant schizophrenia who developed clozapine-induced fever. |
2023-11-24 |
2023-11-28 |
Not clear |
| Marina Coelho Moraes de Brito, Maria Magalhães Vasconcelos Guedes, Janaíra da Silva Nascimento, Victoria Pimentel Jatobá, Murilo Pereira Alves Junior, Adrianne de Carvalho Lira, Pedro Alves da Cruz Gouvei. Diffuse Large B-Cell Lymphoma with Cutaneous Manifestations in a Young Patient Using Clozapine for Schizophrenia: A Case Report. The American journal of case reports. vol 24. 2023-11-21. PMID:37986560. |
diffuse large b-cell lymphoma with cutaneous manifestations in a young patient using clozapine for schizophrenia: a case report. |
2023-11-21 |
2023-11-29 |
Not clear |
| Marina Coelho Moraes de Brito, Maria Magalhães Vasconcelos Guedes, Janaíra da Silva Nascimento, Victoria Pimentel Jatobá, Murilo Pereira Alves Junior, Adrianne de Carvalho Lira, Pedro Alves da Cruz Gouvei. Diffuse Large B-Cell Lymphoma with Cutaneous Manifestations in a Young Patient Using Clozapine for Schizophrenia: A Case Report. The American journal of case reports. vol 24. 2023-11-21. PMID:37986560. |
case report we report a case of a 44-year-old woman diagnosed with schizophrenia 31 years previously, who had been taking clozapine since 2009, presenting with diffuse cutaneous nodules and subcutaneous masses accompanied by asthenia, dry cough, and a weight loss of 12 kg. |
2023-11-21 |
2023-11-29 |
Not clear |
| Anindya Kar, Thomas Nutting, Mohammad Ikram, Charles Sulliva. The clozapine conundrum: Navigating neutropenia and the pursuit of effective care in treatment-resistant schizophrenia. International journal of psychiatry in medicine. 2023-11-16. PMID:37971414. |
the clozapine conundrum: navigating neutropenia and the pursuit of effective care in treatment-resistant schizophrenia. |
2023-11-16 |
2023-11-20 |
Not clear |
| Carmen F M van Hooijdonk, Marieke van der Pluijm, Bart M de Vries, Matthijs Cysouw, Behrooz Z Alizadeh, Claudia J P Simons, Therese A M J van Amelsvoort, Jan Booij, Jean-Paul Selten, Lieuwe de Haan, Frederike Schirmbeck, Elsmarieke van de Giesse. The association between clinical, sociodemographic, familial, and environmental factors and treatment resistance in schizophrenia: A machine-learning-based approach. Schizophrenia research. vol 262. 2023-11-11. PMID:37950936. |
prediction of treatment resistance in schizophrenia (trs) would be helpful to reduce the duration of ineffective treatment and avoid delays in clozapine initiation. |
2023-11-11 |
2023-11-20 |
Not clear |
| Jonathan M Meye. Making sense of norclozapine levels: 3 clinical axioms. Schizophrenia research. 2023-11-09. PMID:37945386. |
laboratories commonly provide norclozapine concentrations when a plasma clozapine level is requested, but the appropriate use of this information for the treatment of individuals with schizophrenia is not always clear. |
2023-11-09 |
2023-11-20 |
Not clear |
| Michelle V Daniels, Suvira Ramlal. Clozapine monitoring at a specialised psychiatric hospital: A retrospective chart review. The South African journal of psychiatry : SAJP : the journal of the Society of Psychiatrists of South Africa. vol 29. 2023-11-06. PMID:37928939. |
clozapine is the only food and drug administration (fda) and national institute for care and excellence (nice) approved drug for treatment-resistant schizophrenia (trs). |
2023-11-06 |
2023-11-08 |
Not clear |
| Atakan Yuce. Critical Feedback on Article by Lee and Colleagues: "Long-Term Outcome of Clozapine in Treatment-Resistant Schizophrenia". Journal of clinical psychopharmacology. vol 43. issue 6. 2023-11-06. PMID:37930219. |
critical feedback on article by lee and colleagues: "long-term outcome of clozapine in treatment-resistant schizophrenia". |
2023-11-06 |
2023-11-08 |
Not clear |
| Myung A Lee, Philip Cola, Karu Jayathilake, Herbert Y Meltze. Reply to Dr Yucel's Comments on the Article "Long-term Outcome of Clozapine in Treatment-Resistant Schizophrenia". Journal of clinical psychopharmacology. vol 43. issue 6. 2023-11-06. PMID:37930220. |
reply to dr yucel's comments on the article "long-term outcome of clozapine in treatment-resistant schizophrenia". |
2023-11-06 |
2023-11-08 |
Not clear |